Status epilepticus associated with sertindole

Eur J Neurol. 2007 Aug;14(8):e12-3. doi: 10.1111/j.1468-1331.2007.01787.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anticonvulsants / therapeutic use
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / pharmacokinetics
  • Brain / drug effects
  • Brain / metabolism
  • Brain / physiopathology
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology
  • Dose-Response Relationship, Drug
  • Electroencephalography / drug effects
  • Female
  • Haloperidol / therapeutic use
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Imidazoles / pharmacokinetics
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Indoles / pharmacokinetics
  • Middle Aged
  • Phenytoin / therapeutic use
  • Receptor, Serotonin, 5-HT2C / metabolism
  • Schizophrenia / drug therapy
  • Serotonin / metabolism
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Antagonists / administration & dosage
  • Serotonin Antagonists / adverse effects*
  • Serotonin Antagonists / pharmacokinetics
  • Status Epilepticus / chemically induced*
  • Status Epilepticus / physiopathology
  • Treatment Outcome

Substances

  • Anticonvulsants
  • Antipsychotic Agents
  • Imidazoles
  • Indoles
  • Receptor, Serotonin, 5-HT2C
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Antagonists
  • Serotonin
  • Phenytoin
  • sertindole
  • Haloperidol